Purple Biotech Ltd ADR (PPBT)
2.67 x 10 2.71 x 1
Pre-market by (Cboe BZX)
2.53 -0.12 (-4.53%) 04/29/25 [NASDAQ]
2.67 x 10 2.71 x 1
Pre-market 2.68 +0.15 (+5.93%) 07:45 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | PPBT | KZIA | VRAX | ||
| Company | Purple Biotech Ltd ADR | Kazia Therapeutics Ltd ADR | Virax Biolabs Group Limited | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.52 | 3.42 | 1.0800 | ||
| High | 2.63 | 3.53 | 1.0800 | ||
| Low | 2.49 | 3.42 | 1.0283 | ||
| Last | 2.53 | 3.47 | 1.0400 | ||
| Change | -0.12 | -0.09 | -0.0700 | ||
| % Change | -4.50% | -2.53% | -6.31% | ||
| Volume | 15,400 | 9,400 | 28,900 | ||
| 20-Day Average Volume | 44,865 | 33,069 | 295,300 | ||
| Previous Close | 2.65 | 3.56 | 1.1100 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.60 | 3.59 | 1.0097 | ||
| 20-Day Raw Stochastic | 36.05% | 46.92% | 42.31% | ||
| 20-Day Relative Strength | 43.21% | 39.93% | 43.91% | ||
| Weighted Alpha | -83.31 | -90.80 | -74.21 | ||
| Today's Opinion | 88% Sell | 100% Sell | 88% Sell | ||
| Previous Opinion | 72% Sell | 100% Sell | 88% Sell | ||
| Last Month's Opinion | 88% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.13% since 04/22/25 | +0.87% since 04/22/25 | +8.33% since 04/22/25 | ||
| Low | 2.37 on 04/28/25 | 3.10 on 04/25/25 | 0.9644 on 04/23/25 | ||
| High | 2.94 on 04/24/25 | 3.88 on 04/25/25 | 1.1300 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | -8.82% since 03/28/25 | -21.15% since 03/28/25 | -10.34% since 03/28/25 | ||
| Low | 2.30 on 04/09/25 | 2.86 on 04/17/25 | 0.8200 on 04/09/25 | ||
| High | 2.94 on 04/24/25 | 4.47 on 03/31/25 | 1.3400 on 04/11/25 | ||
| 3-Month | |||||
| %Chg | -24.68% since 01/29/25 | -49.71% since 01/29/25 | -45.83% since 01/29/25 | ||
| Low | 2.30 on 04/09/25 | 2.86 on 04/17/25 | 0.8200 on 04/09/25 | ||
| High | 3.48 on 02/19/25 | 13.20 on 01/30/25 | 2.2900 on 02/07/25 | ||
| 6-Month | |||||
| %Chg | -27.28% since 10/29/24 | -87.12% since 10/29/24 | -52.29% since 10/29/24 | ||
| Low | 2.00 on 11/22/24 | 2.86 on 04/17/25 | 0.8200 on 04/09/25 | ||
| High | 13.95 on 12/02/24 | 39.05 on 11/04/24 | 3.2000 on 01/06/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,367 | 3,495 | 3,362 | ||
| Shares Outstanding, K | 1,331 | 1,007 | 3,233 | ||
| Annual Sales | 0 | 1,630,000 | 160,000 | ||
| Annual Net Income | -7,240,000 | -17,560,000 | -6,730,000 | ||
| Last Quarter Sales | 0 | 2,897,743 | N/A | ||
| Last Quarter Net Income | 5,760,000 | -4,369,673 | N/A | ||
| 60-Month Beta | 0.62 | 2.28 | 1.81 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 03/10/25 | N/A | N/A | ||
| Latest Earnings Date | 05/20/25 | 02/21/25 | 11/19/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||